JEREMY COPLAN: Open Payments
NPI 1346468600 · MANHASSET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$67,636 in 100 payments from 7 companies in 2025. Trend: 2023 $49,571 · 2024 $40,299 · 2025 $67,636
Speaker / faculty: $38,750Consulting: $17,879Travel & lodging: $4,797Food & beverage: $3,370Honoraria: $2,813Education: $27
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 36 | $42,522 |
| E.R. Squibb & Sons, L.L.C. | 32 | $12,537 |
| ABBVIE INC. | 10 | $5,546 |
| Alkermes, Inc. | 10 | $3,881 |
| Axsome Therapeutics, Inc. | 2 | $2,934 |
| Otsuka America Pharmaceutical, Inc. | 8 | $174 |
| Corium, LLC | 2 | $42 |
Products named: CAPLYTA, VRAYLAR, LYBALVI, Auvelity, COBENFY, REXULTI, Azstarys, ARISTADA.
Industry payments across NY — which companies pay providers there.
